Therapeutic dilemma for restless legs syndrome

New England Journal of Medicine

Volumn 370, Issue 7, 2014, Pages 667-668

  Chokroverty, Sudhansu ^a,b  

^a NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^b SETON HALL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUTAMIC ACID; LEVODOPA; OPIATE; PRAMIPEXOLE; PREGABALIN; TRAMADOL;

BASAL GANGLION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG EFFICACY; EDITORIAL; EPIDEMIOLOGICAL DATA; GENETIC PREDISPOSITION; HUMAN; IRON DEFICIENCY; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SLEEP DISORDER; THALAMOCORTICAL TRACT;

EID: 84893721306     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1313155     Document Type: Editorial

References (12)

1. Ekbom KA. Restless legs: a clinical study. Acta Med Scand Suppl 1945;158:1-123.
2. Allen RP, Walters AS, Chokroverty S. Restless legs syndrome (Willis-Ekbom disease). In: Chokroverty S, Allen RP, Walters AS, Montagna P, eds. Sleep and movement disorders. 2nd ed. New York: Oxford University Press, 2013:598-611.
3. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-92. (Pubitemid 40989594)
4. Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001;16:577-9. (Pubitemid 36041175)
5. Szentkiralyi A, Fendrich K, Hoffmann W, Happe S, Berger K. Incidence of restless legs syndrome in two population-based cohort studies in Germany. Sleep Med 2011;12:815-20.
6. Budhiraja P, Budhiraja R, Goodwin JL, et al. Incidence of restless legs syndrome and its correlates. J Clin Sleep Med 2012;8:119-24.
7. Kagimura T, Nomura T, Kusumi M, Nakashima K, Inoue Y. Prospective survey on the natural course of restless legs syndrome over two years in a closed cohort. Sleep Med 2011;12:821-6.
8. Allen RP. Pathophysiology: the biology of restless legs syndrome (Willis-Ekbom disease). In: Chokroverty S, Allen RP, Walters AS, Montagna P, eds. Sleep and movement disorders. 2nd ed. New York: Oxford University Press, 2013:585-97.
9. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982;39:739. (Pubitemid 12003440)
10. Silver N, Allen RP, Senerth J, Earley CJ. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Med 2011;12:440-4.
11. Allen RP, Chen C, Garcia-Borreguero D, et al. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med 2014;370:621-31.
12. Earley CJ, Allen RP. Restless legs syndrome augmentation associated with tramadol. Sleep Med 2006;7:592-3. (Pubitemid 44488097)